| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $6.4M | +426.3% |
| Cost of Revenue | $3.9M | +140.1% |
| Gross Profit | $2.6M | +744.4% |
| R&D Expense | $5.8M | -47.7% |
| SG&A Expense | $41.8M | +73.6% |
| Operating Income | -$46.4M | -30.5% |
| Pre-tax Income | -$22.5M | +43.2% |
| Income Tax | -$2.4M | -3725.4% |
| Net Income | -$20.0M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $2.8M | +5207.5% |
| Inventory | $1.7M | +440.8% |
| Current Assets | $5.3M | — |
| Total Assets | $39.1M | +349.6% |
| Current Liabilities | $26.1M | +1062.6% |
| Long-term Debt | $3.4M | -48.1% |
| Total Liabilities | $33.6M | +851.9% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.4M | -25.7% |
| Capital Expenditures | $44K | — |
| Investing Cash Flow | -$1.1M | -75.0% |
| Financing Cash Flow | $19.7M | +29.7% |
| Free Cash Flow | -$18.4M | — |
| +49.4% |
| EPS (Basic) | -$0.73 | +73.1% |
| EPS (Diluted) | -$0.75 | +72.3% |
| Stockholders' Equity |
| $5.5M |
| +262.3% |